Abstract:BackgroundDrug repositioning, finding new indications for existing drugs, has gained much recent attention as a potentially efficient and economical strategy for accelerating new therapies into the clinic. Although improvement in the sensitivity of computational drug repositioning methods has identified numerous credible repositioning opportunities, few have been progressed. Arguably the “black box” nature of drug action in a new indication is one of the main blocks to progression, highlighting the need for methods that inform on the broader target mechanism in the disease context.ResultsWe demonstrate that the analysis of co-expressed genes may be a critical first step towards illumination of both disease pathology and mode of drug action. We achieve this using a novel framework, co-expressed gene-set enrichment analysis (cogena) for co-expression analysis of gene expression signatures and gene set enrichment analysis of co-expressed genes. The cogena framework enables simultaneous, pathway driven, disease and drug repositioning analysis. Cogena can be used to illuminate coordinated changes within disease transcriptomes and identify drugs acting mechanistically within this framework. We illustrate this using a psoriatic skin transcriptome, as an exemplar, and recover two widely used Psoriasis drugs (Methotrexate and Ciclosporin) with distinct modes of action. Cogena out-performs the results of Connectivity Map and NFFinder webservers in similar disease transcriptome analyses. Furthermore, we investigated the literature support for the other top-ranked compounds to treat psoriasis and showed how the outputs of cogena analysis can contribute new insight to support the progression of drugs into the clinic. We have made cogena freely available within Bioconductor or https://github.com/zhilongjia/cogena.ConclusionsIn conclusion, by targeting co-expressed genes within disease transcriptomes, cogena offers novel biological insight, which can be effectively harnessed for drug discovery and repositioning, allowing the grouping and prioritisation of drug repositioning candidates on the basis of putative mode of action.

Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking

A simple and robust method for connecting small-molecule drugs using gene-expression signatures

A Comprehensive Evaluation of Connectivity Methods for L1000 Data.

Sscmap: an Extensible Java Application for Connecting Small-Molecule Drugs Using Gene-Expression Signatures

DrugSim2DR: systematic prediction of drug functional similarities in the context of specific disease for drug repurposing

Accelerating drug discovery and repurposing by combining transcriptional signature connectivity with docking

Computational protocol to identify shared transcriptional risks and mutually beneficial compounds between diseases

Clinical connectivity map for drug repurposing: using laboratory tests to bridge drugs and diseases

ReSimNet: drug response similarity prediction using Siamese neural networks

Signature Search Polestar: A comprehensive drug repurposing method evaluation assistant for customized oncogenic signature

Ant colony optimization for the identification of dysregulated gene subnetworks from expression data

ConSIG: Consistent Discovery of Molecular Signature from OMIC Data

Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery

Molecular Signatures from Gene Expression Data

Drugsig: A Resource For Computational Drug Repositioning Utilizing Gene Expression Signatures

Integrating gene regulatory pathways into differential network analysis of gene expression data

Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Systemic Similarity Analysis of Compatibility Drug-Induced Multiple Pathway Patterns in Vivo

Connecting the dots: Computational network analysis for disease insight and drug repurposing

Repurposing Drugs for Infectious Diseases by Graph Convolutional Network with Sensitivity-Based Graph Reduction